Krystal S. Bottom

Phase II study of irinotecan (CPT-11) in children with high-riskmalignant brain tumors: The Duke experience

Christopher D. Turner, Sridharan Gururangan, James D. Eastwood et al. · Neuro-Oncology · 2002 · 84 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas

Albert Moghrabi, Henry S. Friedman, David M. Ashley et al. · Neurosurgical FOCUS · 1998 · 25 citations · Full text

Medicine, Oncology, Pharmacology +16

Trilineage Hematopoietic Toxicity Associated with Valproic Acid Therapy

Krystal S. Bottom, Denise M. Adams, Karen P. Mann et al. · ˜The œAmerican journal of pediatric hematology/oncology · 1997 · 17 citations

Medicine, Hematology, Pharmacology +17

Evaluation of Pre-radiotherapy Cyclophosphamide in Patients with Newly Diagnosed Glioblastoma Multiforme

Krystal S. Bottom, David M. Ashley, Henry S. Friedman et al. · Journal of Neuro-Oncology · 2000 · 11 citations

Medicine, Oncology, Radiation Oncology +14